The framing around digital pathology adoption often focuses on technology — scanner selection, image management platforms, algorithm performance. Less often discussed is the workflow that technology sits inside, and where the actual time goes in an IHC case from specimen receipt to signed report. When we mapped this with early-access partners across multiple academic cancer programs, the finding was consistent: staining and scanning are not the bottleneck. The bottleneck is the manual scoring step, and it is concentrated in a narrow band of high-complexity cases.
The Anatomy of an IHC Turnaround
A standard IHC turnaround for a breast cancer biopsy requesting HER2, ER, PR, and Ki-67 has multiple sequential phases, each with its own time cost and its own sources of variability:
Specimen receipt to section mounting: For a core needle biopsy in 10% neutral buffered formalin, standard pre-analytical processing includes fixation (minimum 6 hours, maximum 72 hours per ASCO/CAP guidelines), paraffin embedding, and sectioning. At most academic centers running a continuous processing schedule, this phase takes 12–24 hours from specimen receipt to stain-ready section, and it is largely irreducible without compromising fixation quality — a real clinical constraint, not an inefficiency.
IHC staining: On an automated immunostainer (Dako Link 48, Ventana BenchMark Ultra, or equivalent), a multi-panel IHC run of 4 markers takes 3–6 hours run time, after which the slides must be dehydrated, coverslipped, and dried. Total from stain order to ready-for-review: 6–8 hours in a well-optimized lab. Capacity-constrained labs with high daily slide volume may batch runs, adding waiting time before the stainer becomes available.
Slide review and scoring: This is where the variability concentrates. A pathologist reviewing a clear-cut HER2 3+ case can complete the score in under 5 minutes. A complex case — heterogeneous HER2 staining, ambiguous 2+/3+ boundary, atypical staining pattern — can take 20–40 minutes including documentation and any required second-opinion consultation. For a panel of 4 markers on a single biopsy, expected review time ranges from 15 minutes (clear-cut cases) to over an hour (complex cases requiring consultation and careful documentation).
Report generation and sign-out: Typing or dictating the IHC addendum, incorporating the scores with required qualitative descriptions, and finalizing the report adds 10–20 minutes per case in most department workflows, depending on templating and dictation infrastructure.
Where the Clock Actually Stops
The cumulative elapsed time from specimen receipt to signed IHC report at academic cancer centers in a standard operational configuration is commonly 24–48 hours for straightforward cases and can extend to 72 hours or more for cases requiring consultation, repeat staining, or ISH reflex testing. The staining and processing phases are relatively fixed. The variable that moves the distribution's tail from 48 to 72+ hours is almost always in the review and documentation phase.
The specific mechanisms are instructive. First, batching effects: at many pathology departments, IHC sign-out happens in dedicated sessions rather than continuously. Cases completed by the staining lab at 3:00 PM may not reach a reviewing pathologist until the next morning's sign-out session — a 12-hour delay that has nothing to do with staining quality or algorithmic performance. Second, consultation queuing: equivocal cases sent to a subspecialty colleague for a second read wait in that colleague's queue, which is often shared with surgical and intraoperative consultations that have higher urgency. Third, manual score documentation: most pathology LIS systems do not have structured fields for IHC scores; pathologists type or dictate narrative descriptions that must be manually read to extract the quantitative result.
What Automation Can and Cannot Address
Algorithmic IHC scoring directly addresses the manual scoring step — replacing a 15–40-minute per-case manual counting and assessment task with a sub-2-minute automated quantification that the reviewing pathologist can verify rather than construct from scratch. For clear-cut cases, this is a modest time savings (15 minutes becomes 2–3 minutes of verification). For complex cases, the savings are larger and more significant: rather than spending 40 minutes constructing a score for a difficult case, the pathologist spends 10–15 minutes critically reviewing an algorithmic assessment with full supporting data.
But automation does not address the batching problem, the consultation queue problem, or the structured data documentation problem — those are workflow and infrastructure issues that require different solutions. We are not saying that algorithmic scoring solves IHC turnaround time in its entirety. The scoring step is the highest-value target for automation because it is the most pathologist-time-intensive part of the workflow, but it is not the only source of delay, and a realistic picture of what automation delivers should distinguish between the types of delays it affects and those it does not.
The Hidden Cost of Manual Scoring
Beyond raw time, manual scoring has a less visible cost: cognitive load. A pathologist who has spent 40 minutes carefully scoring a complex HER2 2+ case has consumed attentional resources that are then unavailable for subsequent cases. This is physiologically real — sustained fine-detail visual attention depletes faster than other cognitive tasks, and the perceptual accuracy of IHC scoring decrements measurably over a long sign-out session.
The implication is that the highest-complexity, highest-stakes cases — the equivocal 2+ cases, the borderline Ki-67 cases near clinical cut-offs, the heterogeneous PD-L1 cases — are exactly the ones most likely to be reviewed under conditions of cognitive fatigue, precisely because they are the ones that consume the most review time earlier in the session. Structured review of an algorithmic output, as opposed to constructing a score from scratch, changes this cognitive profile: the pathologist's task is evaluation and verification, not construction, and that is a less fatiguing activity that preserves more cognitive resources for clinical judgment.
Measuring the Bottleneck in Your Department
Any pathology department considering digital pathology AI should understand its own workflow metrics before evaluating vendor claims. The relevant questions: What is the current mean and 90th-percentile turnaround time for IHC-containing cases? What fraction of cases with IHC requests require ISH reflex testing, and what is the additional turnaround time for those cases? What is the current distribution of review time per case — how long do the most complex 10% of IHC cases take versus the median? How are IHC scores currently documented in the LIS — structured fields, narrative text, or hybrid?
These numbers vary more across institutions than most generic benchmarking studies suggest, because local workflow design, staffing models, and LIS infrastructure each have significant effects. A tool promising a 40% turnaround time reduction derived from data at a high-volume academic center with dedicated IHC sign-out sessions may produce a 15% reduction at a department where IHC sign-out is integrated into general surgical pathology review and the scoring step is a smaller fraction of total case time. Understanding your specific bottleneck is the prerequisite to evaluating whether any particular solution addresses it.
The goal is not to be faster for the sake of speed. It is to return the pathologist's time to the high-judgment activities — clinical correlation, interdisciplinary communication, case consultation — where pathology expertise creates the most value, and to remove the repetitive manual quantification step that currently consumes a disproportionate share of it.